Friday morning, Biogen Idec announced positive results related to its Alzheimer's study. Any real Alzheimer's drug certainly would make the blockbuster category.
Chris Lange Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.
One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases.
24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with the mid-February figures. Across the board, all the selected stocks have seen…
24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay dividends to their shareholders.
A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money managers love and are staying with.
The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
24/7 Wall St. wanted to find out which of the major Nasdaq stocks would lead the index back over 5,000 -- and perhaps ultimately to new all-time highs.
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
Biogen Idec shares hit a new multiyear high Friday morning following the better-than-expected fourth-quarter earnings.
Chris Lange 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that…
A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have some huge upside potential to the posted price targets.
